EVOFEM BIOSCIENCES, INC.: 10-K filed 2016-03-29
What EVOFEM BIOSCIENCES, INC. reported in its annual report filed 2016-03-29 (fiscal FY 2015): 21 published measures, 52 facts as tagged in accession 0001564590-16-015451.
This filing
- Form
- 10-K (annual report)
- Filed
- 2016-03-29
- Fiscal period
- fiscal FY 2015
- Accession
- 0001564590-16-015451 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All EVOFEM BIOSCIENCES, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 40,111,972 | USD | |
| At 2014-12-31 | 76,898,098 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 23,807,295 | USD | |
| At 2014-12-31 | 65,247,429 | USD | |
| At 2013-12-31 | -56,691,362 | USD | |
| At 2012-12-31 | -41,755,596 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 37,748,603 | USD | |
| At 2014-12-31 | 75,947,516 | USD | |
| At 2013-12-31 | 4,364,007 | USD | |
| At 2012-12-31 | 11,099,858 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-12-31 | -43,157,045 | USD | 365 |
| 2014-01-01 to 2014-12-31 | -10,819,236 | USD | 365 |
| 2013-01-01 to 2013-12-31 | -15,016,253 | USD | 365 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-12-31 | 226,128 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 18,078 | USD | 365 |
| 2013-01-01 to 2013-12-31 | 21,157 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | -112,831,757 | USD | |
| At 2014-12-31 | -69,674,712 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-12-31 | 0 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 0 | USD | 365 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 186,372 | USD | |
| At 2014-12-31 | 24,809 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-12-31 | 1,578,279 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 612,952 | USD | 365 |
| 2013-01-01 to 2013-12-31 | 80,487 | USD | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-12-31 | -42,049,091 | USD | 365 |
| 2014-01-01 to 2014-12-31 | -9,591,057 | USD | 365 |
| 2013-01-01 to 2013-12-31 | -14,422,686 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 39,725,600 | USD | |
| At 2014-12-31 | 76,873,289 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 9,099,501 | USD | |
| At 2014-12-31 | 1,909,589 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 4,017,192 | USD | |
| At 2014-12-31 | 997,269 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-12-31 | 42,049,091 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 9,591,057 | USD | 365 |
| 2013-01-01 to 2013-12-31 | 14,422,686 | USD | 365 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-12-31 | 34,409,664 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 5,174,876 | USD | 365 |
| 2013-01-01 to 2013-12-31 | 11,447,844 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 13,750,016 | shares | |
| At 2014-12-31 | 13,671,311 | shares |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 279,547 | USD | |
| At 2014-12-31 | 153,460 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 93,175 | USD | |
| At 2014-12-31 | 128,651 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 1,976,997 | USD | |
| At 2014-12-31 | 925,773 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-12-31 | 7,639,427 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 4,416,181 | USD | 365 |
| 2013-01-01 to 2013-12-31 | 2,974,842 | USD | 365 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | -47,306 | USD | 365 |
Inspect the source
- Entity
- EVOFEM BIOSCIENCES, INC. / CIK 0001618835
- Captured
- SEC response SHA-256
c8bf3bae341cb8de34e01a708b32050739ddc460f13010d7d1bd9abd1c4dd597
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001618835.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))